Cel-Sci
CVM
#9964
Rank
A$42.77 M
Marketcap
A$5.06
Share price
1.98%
Change (1 day)
-61.58%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -A$38.73 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$37.32 Million, an increase over its 2023 earnings that were of -A$42.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.73 Million3.78%
2024 -A$37.32 Million-12.41%
2023 -A$42.61 Million-12.87%
2022 -A$48.9 Million-3.42%
2021 -A$50.64 Million13.44%
2020 -A$44.64 Million11.28%
2019 -A$40.11 Million179.81%
2018 -A$14.34 Million-48.72%
2017 -A$27.96 Million-16.23%
2016 -A$33.37 Million-23.63%
2015 -A$43.7 Million-5.47%
2014 -A$46.23 Million198.49%
2013 -A$15.49 Million
2010 -A$18.08 Million
2004 -A$6.11 Million12.38%
2003 -A$5.44 Million-16.59%
2002 -A$6.52 Million-59.28%
2001 -A$16.01 Million23.17%
2000 -A$13 Million20.12%
1999 -A$10.82 Million13.24%
1998 -A$9.56 Million-20%
1997 -A$11.94 Million46.55%
1996 -A$8.15 Million34.88%
1995 -A$6.05 Million2.38%
1994 -A$5.9 Million68%
1993 -A$3.52 Million78.57%
1992 -A$1.97 Million180%
1991 -A$0.71 Million25%
1990 -A$0.57 Million-0%
1989 -A$0.57 Million-71.43%
1988 -A$1.97 Million-0%
1987 -A$1.97 Million-46.15%
1986 -A$3.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.50 B-130,928.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.58 B-33,392.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-A$0.2 Billion 457.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-A$45.74 Million 31.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.02 B-8,790.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-A$9.3 Million-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-767.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.33 Million-61.68%๐Ÿ‡บ๐Ÿ‡ธ USA